- LYRA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
-
Institutional
- Shorts
Lyra Therapeutics (LYRA) Institutional ownership
Company Profile
Type | Filer | #Shares | Filed | For date | #Previous | %Chg | Prev. Date |
---|---|---|---|---|---|---|---|
SC 13D/A
|
Perceptive Advisors | 12.76 mm | 16 Dec 24 | 12 Dec 24 | 12.76 mm | 0% | 30 Sep 24 |
13F-HR
|
Catalyst Funds Management Pty | 8.20 k | 4 Dec 24 | 31 Mar 24 | 0.00 | +∞% | - |
13F-HR
|
BRYN MAWR TRUST | 1.02 k | 25 Nov 24 | 30 Sep 24 | 0.00 | +∞% | 30 Jun 24 |
13F-HR/A
|
Barclays | 63.30 k | 19 Nov 24 | 30 Sep 24 | 16.60 k | +281% | 30 Jun 24 |
13F-HR
|
Barclays | 63.30 k | 15 Nov 24 | 30 Sep 24 | 16.60 k | +281% | 30 Jun 24 |
13F-HR/A
|
National Bank of Canada | 3.70 k | 14 Nov 24 | 30 Sep 24 | 3.70 k | 0% | 30 Jun 24 |
SC 13G/A
|
Point72 Asset Management, L.P | 0.00 | 14 Nov 24 | 30 Sep 24 | 0.00 | 30 Jun 24 | |
13F-HR
|
Jane Street | 51.84 k | 14 Nov 24 | 30 Sep 24 | 37.08 k | +40% | 30 Jun 24 |
SC 13G/A
|
Venrock Healthcare Capital Partners II, L.P | 1.20 mm | 14 Nov 24 | 30 Sep 24 | 5.55 mm | -78% | 31 Dec 23 |
SC 13G/A
|
Samsara BioCapital, L.P | 3.28 mm | 14 Nov 24 | 30 Sep 24 | 2.78 mm | +18% | 12 Apr 22 |
This data is updated daily from 13F, 13D and 13G SEC filings.
Faded values represent incomplete data for the quarter, where values have been used from the previous quarter for institutions that haven't filed updated data yet.
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.